MedCity News October 18, 2024
This technological shift not only boosts efficiency and profitability for pharmaceutical companies but also speeds up the delivery of innovative therapies to patients.
Currently, a significant portion of the capital being invested in the discovery space is directed towards artificial intelligence, with a particular focus on discovery processes. This growing technology promises to revolutionize how biological modules are identified and optimized. For companies operating in this sphere, it is imperative to prepare adequately for the surge in productivity that AI-driven discovery will bring.
To manage the increased volume in the pipeline, companies typically resort to adopting advanced technologies or expanding their workforce to enhance capabilities. While it is natural for companies to hire more personnel, they encounter two major challenges:...
Today's Sponsors
Today's Sponsor